BEST UNLIMITED TURBO LONG CERTIFICATE - ELI LILLY & CO | Market Closed - Borsa Italiana 03:39:01 2024-06-27 pm EDT | ||
| 21.09 EUR | +1.64% |
|
| Current month | +54.91% | ||
| 1 month | +62.07% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-27 | 21.09 | +1.64% |
| 24-06-26 | 20.75 | -0.43% |
| 24-06-25 | 20.84 | +5.57% |
| 24-06-24 | 19.74 | +2.23% |
| 24-06-21 | 19.31 | -0.21% |
Real-time Borsa Italiana
Last update June 27, 2024 at 03:39 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
Société Générale
|
| S34178 | |
| ISIN | DE000SU9FM05 |
| Date issued | 2024-02-20 |
| Strike | 683.3 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | - € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 21.72 € |
|---|---|
| Lowest since issue | 4.88 € |
| Spread | 0.16 € |
| Spread % | 0.76% |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
901.3
USD
Average target price
860.5
USD
Spread / Average Target
-4.52%
- Stock Market
- Certificates
- S34178 Certificat
